Hierarchical Clustering Analysis for Predicting 1-Year Mortality After Starting Hemodialysis
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Prospective single-centre cohort of 101 patients newly starting hemodialysis: hierarchical clustering over 46 clinical variables identified a subgroup associated with the highest 1-year mortality (age/sex-adjusted HR 10.2, 95% CI 2.94–46.8). This is a source-reported observational association, not a validated biological subtype, causal explanation, or treatment recommendation.
Technology: Ward agglomerative hierarchical clustering with K-means sensitivity analysis
Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Ward hierarchical clustering grouped 101 new hemodialysis patients on standardized clinical variables; the clusters were associated with one-year mortality, with K-means used as a sensitivity analysis.
- Limitation / still unknown
- Affiliation was not available in the reviewed primary bibliographic metadata. Publication status could not be established from the reviewed primary bibliographic metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7403509/ · https://europepmc.org/article/MED/32775818 · https://pubmed.ncbi.nlm.nih.gov/32775818/
The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.